Skip to main content

Avidity Partners Management LP

SEC CIK
0001791827
Latest filing
Aug 14, 2026

CRVS holding history

Corvus Pharmaceuticals, Inc. in every 13F filed by Avidity Partners Management LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRVS overviewAll 13F holders of CRVSFull Q2 2026 holdings

Shares (Q2 2026)
80,000
Value
$1.20M
% of portfolio
0.2%
Quarters held
2
Since Q1 2026
Holdings of CRVS by Avidity Partners Management LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202680,000$1.20M0.2%−35,000−30.4%ReducedHolders
Q1 2026115,000$1.68M0.3%+115,000NewHolders